Dogsee Chew raises 50 Cr in Series A from Mankind Pharma

Insight Online News

Mumbai,Jan 19 : Dogsee Chew, India’s fastest growing natural pet treat brand, has raised Rs 50 crores in Series A round from Mankind Pharma along with existing backer Sixth Sense Ventures.

This marks the Mankind Pharma’s entry into the pet food category. Sixth Sense Ventures had also earlier participated in the company’s pre-series A funding in November 2021.

Talking about the investment, Dogsee Chew founder Bhupendra Khanal said, “Our products are the result of years of careful research focused on the precise nutritional needs of dogs. We put research and innovation at the heart of everything we do. The more we understand, the better placed we are to make a positive difference to the health and well-being of pets. Mankind pharma has an established history of creating highly successful consumer products. Having the backing of such a giant is a huge vote of confidence for us and we look forward to learning from their expertise.”

Sneh Sharma, Dogsee Chew co-founder mentioned, ”With Mankind, we share the common DNA of innovation. We are confident that with their support, we will be able to develop the niche that we have envisioned for the brand.” She also added, “Sixth Sense Ventures has been a great partner for us.

We are excited to be deepening our partnership with this round. It speaks a lot about the trust and comfort we have established between us in such a short span of time.”

The investment will primarily be used towards brand building, R&D, and building a strong distribution network.

Speaking of their investment in Dogsee Chew, Mr Arjun Juneja Chief Operations Officer of Mankind Pharma said, ”The trust that people have shown in Dogsee Chew has strengthened our confidence to invest in a brand that is true to its nature. Mankind has always believed in innovation and, with brands like Dogsee Chew that are innovative & young, we see the future of India.”

UNIINDIA

Leave a Reply

Your email address will not be published.